Ventral Prostate Fibrosis in the Akita Mouse Is Associated with Macrophage and Fibrocyte Infiltration
A higher incidence of lower urinary tract symptoms (LUTS) among diabetic men is unexplained. Recently, prostate inflammation and fibrosis have been implicated as major contributing factors to bladder outlet obstruction and LUTS. We characterized the inflammatory cell infiltrate and collagen content of the anterior, dorsal, and ventral lobes of 18-week-old DBA2J.Ins2-Akita mice (Akita) and age-matched control mice. We performed hematoxylin and eosin staining to score tissue injury and inflammation, picrosirius red staining to quantitate collagen content, and immunostaining to identify monocytes/macrophages and infiltrating fibrocytes. We observed significantly greater numbers of monocytes/macrophages and fibrocytes specifically in the ventral prostate of the Akita mice and found that this was associated with significant greater collagen content specifically in the ventral prostate of the Akita mice. These observations support the inference that diabetes elicits monocyte/macrophage infiltration and collagen accumulation in the prostate and suggest that further study of Akita mice may inform translational studies of diabetes in the genesis prostatic inflammation, prostatic fibrosis, and LUTS.
Lower urinary tract symptoms (LUTS) in aging men have historically been ascribed to enlargement of the prostate gland referred to as benign prostatic hyperplasia (BPH). However, there is growing appreciation that the genesis of LUTS is likely multifactorial and, in addition to prostate enlargement, is likely to include age-related changes in bladder function, autonomic dysregulation, and metabolic influences . Recently, prostate inflammation was identified as very strongly associated with severity of symptoms and prostatic fibrosis was associated both with irritative voiding symptoms such as urinary frequency and urgency and with diminished urine flow [2, 3].
Men diagnosed with symptomatic BPH have a higher incidence of diabetes than the general population . Postulated mechanisms for this association include increased sympathetic tone, stimulation of prostate growth by insulin, alterations in steroid hormone secretion, inflammation, and oxidative stress. Given recent clinical studies implicating prostate inflammation and fibrosis in the genesis of LUTS, we examined the prostate of mouse model of type 1 diabetes (DBA2J.Ins2-Akita) for evidence of inflammation and/or fibrosis. This work was supported as a pilot study by the NIH Animal Model of Diabetic Complication Consortium (AMDCC).
2. Materials and Methods
2.1. Animals and Tissue Collection
Heterozygous DBA2J.Ins2-Akita (Akita) female and male mice (The Jackson Laboratory, strain number 007562, Bar Harbor, ME) were obtained for breeding. All procedures in this study were performed with 18-week-old heterozygous Akita male mice and wild type controls (WT) as approved by the Institutional Animal Care and Use Committee, University of Wisconsin-Madison. The tip of the tail from each male adult mouse were collected and sent to Transnetyx, Inc. for genotyping (Cordova, TN). At 18 weeks of age, each prostatic lobe (AP, DLP, and VP) was identified as described earlier  and harvested. Collected anterior prostate , dorsal lateral prostate (DLP), and ventral prostate (VP) were rinsed in DPBS and fixed in 10% formalin. Paraffin embedded tissues were serially sectioned (5 μm). Three random areas from each prostatic lobe from each animal were acquired for H&E (Thermo Scientific, Waltham, MA, Anatech LTD, Battle Creek, MI) staining (WT: ; diabetic: ).
2.2. Characterization of Inflammatory Cells
The number and type of inflammatory cells were characterized in the prostate of Akita and WT mice. Three random areas from each prostatic lobe from each animal were acquired (WT: ; diabetic: ). Neutrophils were identified and quantitated in H&E stained sections. Immunohistochemistry was used to quantitate monocytes/macrophages, T lymphocytes, B lymphocytes, and fibrocytes. Briefly, sections were blocked for 4 hours in PBS containing 10% donkey serum and 1% BSA (both from Sigma-Aldrich, St. Louis, Missouri) was followed by primary antibodies-rat anti-F4/80 (1 : 50, eBioscience, San Diego, CA), rabbit anti-CD3 (1 : 100, Dako, Carpinteria, CA) and goat anti-CD20 (1 : 100, Santa Cruz, Santa Cruz, CA), and rat anti-CD45 (1 : 100, Abcam, Cambridge, MA) and rabbit anti-vimentin (1 : 100, Abcam, Cambridge, MA) overnight at 4 degrees. Secondary antibodies-donkey anti-rat Alexa 594, donkey anti-rabbit Alexa 594, donkey anti-rat Alexa 488, and donkey anti-goat Alexa 488 (1 : 100, Invitrogen, Grand Island, NY) were incubated for one hour at room temperature. Four μg/mL of Hoechst 33258 (Sigma-Aldrich, St. Louis, Missouri) was incubated for 10 minutes. For quantification of each cell type, three random areas from each prostatic lobe from each animal were acquired using Nikon eclipse Ti-U microscope.
2.3. Collagen Quantification
Picrosirius red staining was performed with serially sectioned tissues. Paraffin embedded tissues were incubated in 0.1% sirius red solution for an hour at room temperature. Three random areas from each prostatic lobe from each animal were acquired (WT: ; diabetic: ) using a Spot-advanced camera on an Olympus BX51 microscope. Areas of positive staining were quantitated using MacBiophotonics Image J.
Comparisons within each prostatic lobe between Akita and WT mice were performed by a two-sample -test. We employed ANOVA with multiple comparisons using Fisher’s protected least significant difference tests. Prior to analysis, all values were rank-transformed in order to better meet the assumptions of ANOVA. values less than 0.05 were considered as significant. All analysis was performed using SAS statistical software versions 9.1 and 9.2 (SAS Institute Inc., Cary, NC).
3.1. Increased Monocytes/Macrophages in the VP and AP of Akita Mice
Prostate lobes from 18-week-old Akita and WT mice were examined for evidence of tissue injury and inflammation by routine H&E staining and scoring according to a previously published scoring system . (see Figure 1 in Supplementary Material available online at http://dx.doi.org/10.1155/2014/939053). We observed no evidence of increased tissue damage, epithelial atypia or atrophy, or reactive hyperplasia. Mild inflammation was observed in all WT mice examined and three of four Akita mice (Figures 1(a), 1(b), 1(d), 1(e), 1(g), and 1(h)). The prostate from one Akita mouse exhibited severe inflammation (Figures 1(c), 1(f), and 1(i)). In order to identify any qualitative difference in the inflammatory infiltrate in WT and Akita mice, we performed immunostaining for different inflammatory cell subsets (Figure 2). For both WT and Akita mice, the infiltrate was composed primarily of T lymphocytes and monocytes/macrophages. This comparison revealed no difference in the number of neutrophils, T lymphocytes, or B lymphocytes between the WT and Akita mice. However, the number of monocytes/macrophages was significantly increased in the VP and AP of Akita mice as compared to WT. When the one Akita mouse with severe inflammation was excluded from the analysis, the number of monocytes/macrophages in the VP was still significantly increased.
3.2. Increased Collagen Deposition and Fibrocyte Infiltrate in the VP of Akita Mice
We performed picrosirius red staining to compare collagen content in the WT and Akita mice. We observed significantly increased staining in the VP of Akita mice, a difference that remained significant even when we excluded the Akita mouse with severe inflammation (Figure 3). Fibrocytes have recently been identified as playing a key role in tissue fibrosis. These cells originate from bone-marrow derived circulating monocytes and have an intermediate phenotype of fibroblasts and macrophages. Costaining for CD45 and vimentin was performed to identify and quantitate fibrocytes in the prostate lobes of WT and Akita mice. The number of fibrocytes was significantly increased in the VP of Akita mice as compared to WT controls (Figure 4). The number of fibrocytes was still significantly increased in the VP even when we excluded the animal with severe inflammation.
Our studies revealed increased collagen content in the VP of Akita mice as compared to age-matched controls. This conclusion is based on increased picrosirius red staining. Picrosirius red staining is considered a reliable indicator of collagen content and has been tightly correlated with tissue hydroxyproline content by a colorimetric assay  and HPLC (manuscript in preparation). Increased picrosirius red staining can result from increased collagen synthesis, decreased collagen degradation, or enhanced collagen cross-linking . These are all changes associated with persistent wound healing—a feature of repeated injury, chronic inflammation, and prolonged cytokine release—and are cardinal aspects of fibrosis [10, 11]. The specificity of fibrosis for the VP of the Akita mouse is unexplained; however, it does echo a previous report of thickened collagen fibrils in the VP of a type 1 diabetic rat [12, 13]. Similarly, Cagnon et al. reported thickening of the extracellular matrix and reduced cell height of glandular epithelium in the VP of Streptozotocin-treated mice . One of the things that confounds prostate research in rodents is the lack of correlation between the lobes of the rodent prostate and the zones of the human prostate as the anatomic and gene expression profiles for the lobes and zones are incongruent . Work in various models has shown changes both in the VP [12–14] and in the DLP [16, 17]. These studies resonate with a larger body of work reporting an association of tissue inflammation and fibrosis in multiple organ systems in diabetes [6, 18–23].
It has been previously reported that tissue injury and inflammation and/or senescence results in increased collagen deposition [10, 16]. However, histologic examination and scoring of tissue damage and inflammation revealed no increase in tissue damage or generalized inflammatory infiltrate in the VP of Akita mice as compared to WT controls. However, we observed that monocyte/macrophage infiltration was significantly increased in the VP and AP of Akita mice as compared to WT controls. Monocyte/macrophage infiltration is a feature of cellular immunity that has been noted in the glomeruli of Akita mice  and Streptozotocin-induced diabetic mice  and speculated to be the source of proinflammatory cytokines that promote glomerulosclerosis . Given these precedent findings, our observations might reflect a functional connection between monocyte/macrophage infiltration and VP fibrosis.
Recent studies have identified fibrocytes as having a primary role in collagen synthesis in tissue remodeling and inflammation . These cells are bone marrow derived cells that take up residence in the tissue and exhibit costaining for CD45 and vimentin. Our unpublished studies of bacterial-induced prostate inflammation show robust numbers of CD45+/vimentin+ cells that costain for prolyl-4-hydroxylase, an enzyme catalyzing the formation of 4-hyroxyproline . We found that CD45+/vimentin+ cells were significantly increased in the VP of Akita mice and suggest a role for fibrocytes in VP fibrosis.
The increased incidence of LUTS in diabetic men is as yet unexplained. Postulated mechanisms include accelerated rates of prostatic enlargement, bladder muscle dysfunction, and neuropathic effects on bladder function [2, 28, 29]. Given recent studies suggesting that fibrosis of the prostate produces a change in prostatic compliance that impairs opening of the bladder neck during voiding, our studies suggest that fibrosis instigated by monocyte/macrophage infiltration may be one mechanism by which diabetes contributes to development of LUTS in men. The possible effect of prostate fibrosis on opening of the bladder neck is uniquely important in humans because the encapsulated prostate completely surrounds the bladder neck and urethra. Since the prostate in mice is not encapsulated and the arrangement of the prostate and bladder neck is such that fibrosis would not be expected to impinge on either the bladder neck or urethra, we are unable to specifically evaluate the effect of the fibrosis we observe on voiding function in this model. Even so, it is a valuable model in which mechanistic studies may be performed to understand how diabetes-induced inflammation induces prostatic fibrosis.
These observations support the inference that diabetes elicits monocyte/macrophage/fibrocyte infiltration and collagen accumulation in the ventral prostate and suggest that further study of Akita mice may inform translational studies of diabetes in the genesis of BPH, prostatic inflammation and fibrosis, and LUTS.
|Akita:||DBA2J.Ins2-Akita (heterozygous diabetic)|
|AMDCC:||Animal Models of Diabetic Complications Consortium|
|BPH:||Benign prostatic hyperplasia|
|DLP:||Dorsal lateral prostate|
|LUTS:||Lower urinary tract symptoms|
Wade Bushman is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
Wade Bushman had overall responsibility for the development of ideas, experimental designs, and paper preparation. Sanghee Lee generated the experimental designs and executed all of the experiments and was the primary author of the paper. Guang Yang and William Mulligan provided technical assistance in the studies and analyses reported. Jerry Gipp provided assistance in generating the figures for the paper.
This work is supported by AMDCC 23789-12. We gratefully acknowledge the assistance of Dr. Glen Leverson in the Department of Surgery and Chee Paul Lin in the Department of Urology at the University of Wisconsin-Madison in statistical analysis and Dr. Edward Leiter in the Jackson Laboratory for helpful discussions of the DBA2J.Ins2-Akita mouse.
The tissue was graded in three randomly selected 20x fields of H&E stained sections according to three criteria; inflammatory infiltrate, tissue damage and hyperplasia based on the criteria shown in previous publication (reference #7). Total score in each field was calculated as intensity x focality. Inflammatory infiltrate is the only criteria showing significant difference between 18 week old Akita and WT mice in the DLP.
W. Bushman, “Etiology, epidemiology, and natural history,” Urologic Clinics of North America, vol. 36, no. 4, pp. 403–415, 2009.View at: Publisher Site | Google Scholar
J. Ma, M. Gharaee-Kermani, L. Kunju et al., “Prostatic fibrosis is associated with lower urinary tract symptoms,” The Journal of Urology, vol. 188, no. 4, pp. 1375–1381, 2012.View at: Publisher Site | Google Scholar
E. Bercovich, G. Barabino, F. Pirozzi-Farina, and M. Deriu, “A multivariate analysis of lower urinary tract ageing and urinary symptoms: the role of fibrosis,” Archivio Italiano di Urologia, Andrologia, vol. 71, no. 5, pp. 287–292, 1999.View at: Google Scholar
J. K. Parsons, H. Ballentine, A. W. Partin et al., “Metabolic factors associated with benign prostatic hyperplasia,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 7, pp. 2562–2568, 2006.View at: Publisher Site | Google Scholar
Y. Sugimura, G. R. Cunha, and A. A. Donjacour, “Morphogenesis of ductal networks in the mouse prostate,” Biology of Reproduction, vol. 34, no. 5, pp. 961–971, 1986.View at: Google Scholar
D. Zechner, N. Knapp, A. Bobrowski, T. Radecke, B. Genz, and B. Vollmar, “Diabetes increases pancreatic fibrosis during chronic inflammation,” Experimental Biology and Medicine. In press.View at: Google Scholar
B. J. Boehm, S. A. Colopy, T. J. Jerde, C. J. Loftus, and W. Bushman, “Acute bacterial inflammation of the mouse prostate,” Prostate, vol. 72, no. 3, pp. 307–317, 2012.View at: Publisher Site | Google Scholar
J. Nagano, M. Shimizu, T. Hara et al., “Effects of indoleamine 2, 3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation,” PLoS ONE, vol. 8, no. 9, Article ID e73404, 2013.View at: Publisher Site | Google Scholar
T. R. Cox, D. Bird, A.-M. Baker et al., “LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis,” Cancer Research, vol. 73, no. 6, pp. 1721–1732, 2013.View at: Publisher Site | Google Scholar
T. A. Wynn, “Cellular and molecular mechanisms of fibrosis,” Journal of Pathology, vol. 214, no. 2, pp. 199–210, 2008.View at: Publisher Site | Google Scholar
W. McKleroy, T. H. Lee, and K. Atabai, “Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 304, no. 11, pp. L709–L721, 2013.View at: Publisher Site | Google Scholar
D. L. Ribeiro, E. J. Caldeira, E. M. Cândido, A. J. Manzato, S. R. Taboga, and V. H. Cagnon, “Prostatic stromal microenvironment and experimental diabetes,” European Journal of Histochemistry, vol. 50, no. 1, pp. 51–60, 2006.View at: Google Scholar
D. L. Ribeiro, S. R. Taboga, and R. M. Góes, “Diabetes induces stromal remodelling and increase in chondroitin sulphate proteoglycans of the rat ventral prostate,” International Journal of Experimental Pathology, vol. 90, no. 4, pp. 400–411, 2009.View at: Publisher Site | Google Scholar
V. H. A. Cagnon, A. M. Camargo, R. M. Rosa, R. Fabiani, C. R. Padovani, and F. E. Martinez, “Ultrastructural study of the ventral lobe of the prostate of mice with streptozotocin induced diabetes (C57BL/6J),” Tissue and Cell, vol. 32, no. 4, pp. 275–283, 2000.View at: Publisher Site | Google Scholar
G. L. Powers and P. C. Marker, “Recent advances in prostate development and links to prostatic diseases,” Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol. 5, no. 2, pp. 243–256, 2013.View at: Google Scholar
M. Gharaee-Kermani, J. A. Rodriguez-Nieves, R. Mehra et al., “Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model,” The Prostate, vol. 73, no. 10, pp. 1123–1133, 2013.View at: Publisher Site | Google Scholar
Y. Sugimura, M. Sakurai, N. Hayashi, A. Yamashita, and J. Kawamura, “Age-related changes of the prostate gland in the senescence-accelerated mouse,” The Prostate, vol. 24, no. 1, pp. 24–32, 1994.View at: Google Scholar
C. L. Lin, “Cannabinoid receptor 1 disturbance of PPARgamma2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli,” Journal of Molecular Medicine. In press.View at: Google Scholar
Y. Liu, Y. Wang, X. Miao et al., “Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ-induced diabetes,” Journal of Cellular and Molecular Medicine, 2014.View at: Publisher Site | Google Scholar
S. P. Hartono, B. E. Knudsen, L. O. Lerman et al., “Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice,” BMC Nephrology, vol. 15, no. 1, article 58, 2014.View at: Publisher Site | Google Scholar
Y. Wang, Z. Zhang, W. Sun et al., “Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of nrf2 expression and function,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 123963, 11 pages, 2014.View at: Publisher Site | Google Scholar
S. P. Cartland, J. H. Erlich, and M. M. Kavurma, “TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE-/- mice,” PLoS ONE, vol. 9, no. 3, Article ID e92952, 2014.View at: Google Scholar
V. Delghingaro-Augusto, L. Madad, A. Chandra et al., “Islet inflammation, hemosiderosis, and fibrosis in intrauterine growth-restricted and high fat-fed sprague-dawley rats,” The American Journal of Pathology, vol. 184, no. 5, pp. 1446–1457, 2014.View at: Publisher Site | Google Scholar
S. M. Morris Jr., T. Gao, T. K. Cooper, D. Kepka-Lenhart, and A. S. Awad, “Arginase-2 mediates diabetic renal injury,” Diabetes, vol. 60, no. 11, pp. 3015–3022, 2011.View at: Publisher Site | Google Scholar
F. Y. Chow, D. J. Nikolic-Paterson, R. C. Atkins, and G. H. Tesch, “Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis,” Nephrology Dialysis Transplantation, vol. 19, no. 12, pp. 2987–2996, 2004.View at: Publisher Site | Google Scholar
G. Proctor, T. Jiang, M. Iwahashi, Z. Wang, J. Li, and M. Levi, “Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes,” Diabetes, vol. 55, no. 9, pp. 2502–2509, 2006.View at: Publisher Site | Google Scholar
R. A. Reilkoff, R. Bucala, and E. L. Herzog, “Fibrocytes: emerging effector cells in chronic inflammation,” Nature Reviews Immunology, vol. 11, no. 6, pp. 427–435, 2011.View at: Publisher Site | Google Scholar
J. A. Rodriguez-Nieves and J. A. Macoska, “Prostatic fibrosis, lower urinary tract symptoms, and BPH,” Nature Reviews Urology, vol. 10, no. 9, pp. 546–550, 2013.View at: Google Scholar
F. Cantiello, A. Cicione, A. Salonia et al., “Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study,” Urology, vol. 81, no. 5, pp. 1018–1023, 2013.View at: Publisher Site | Google Scholar